Bioline Rx (YP2.F) Q4 2024 Earnings

Nov 25Confirmed
Q4 2024
-0
-0
-0
0

Details

Expected EPS
-0.0027654848900000003
Actual EPS
0
Surprise EPS
0
Surprise Percent
+100%

Description

⁨Bioline Rx⁩ (⁦YP2.F⁩) has reported earnings of ⁦0⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts